Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis
Clinical trial NCT02728934 · COMPLETED
Trial details
- NCT number
- NCT02728934
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-02-25
- Primary completion
- 2020-01-31
- Enrollment
- 1279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.